Health

Hong Kong-led trials show patients with rare liver cancer can live longer by undergoing combined treatments




Six-year study led by Chinese University found that chemotherapy plus targeted radiotherapy could extend patients’ lives by 22 months.



READ SOURCE

See also  How the Impossible Burger is changing the debate over GMO foods